JERUSALEM--(Marketwire - July 02, 2012) -
IDenta Corp. (PINKSHEETS: IDTA
) CEO Yaacov Shoham today announced that the company has developed new drug detectors (field test kits), for Synthetic Cannabinoids and for Bath Salt.
1. Synthetic Cannabinoids drugs have become a major problem all over the world.
IDenta has developed a field testing kit for detecting these Synthetic Cannabinoids as pure substances and as a substance absorbed on plant material. This is the first time that a company has developed this type of detector. As far as we know, no other company has developed such detectors and probably the other companies will not be able to develop it because they do not have R&D departments. IDenta is the only company that has an R&D department.
IDenta has already applied to obtain a patent for the Synthetic Cannabinoids drug detectors.
2. At the same time we at IDenta have developed a kit for another major world problem -- Bath Salts.
Bath Salts are analogs of Ecstasy drugs and are detected by IDenta's already patented field testing kit for Ecstasy.
3. Mr. Shoham commented, "We have been working on new inventions and developments for the past 18 months. We at IDenta do believe that we will be in a short time the only 'supermarket' for the specific forensics products. We will have all kind of detectors and methods for detecting suspected substances. Additional details will be released in the July-August months."
IDenta's entire product line may be found at www.Identa-corp.com, www.drugsdetector.com and www.Identa.biz
Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, email@example.com, www.drugsdetector.com www.identa.biz www.identa-corp.com